Veracyte Q4 revenue $80.3M (+19% YoY); full-year $296.5M (+35%); net loss narrows 63%

VERACYTE, INC.

2022-FY EPS reported -$0.51 revenue$296,536,000

Q4 2022 revenue $80.3M (up 19% YoY); testing revenue $70.3M (+32%); net loss $3.8M (improved 63%).
Full-year 2022 revenue $296.5M (+35%); net loss $36.6M (improved 52%); EPS -$0.51 (improved 54%).
Total test volume 28,001 in Q4 (+26% YoY) and 102,524 for full year (+30%).
Generated $9.7M cash from operations in Q4; ended year with $178.9M cash and investments.
Promoted Annie McGuire to General Counsel and Chief People Officer.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.